비허형 아토피 동물모델 개발
Development of Atopic Dermatitis Mouse Model with Spleen Deficiency
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Atopic dermatitis (AD) is a common skin disease characterized by chronic and relapsing inflammatory dermatitis with immunological disturbances. Spleen deficiency (脾虛) is one of the major causes of AD, so development of animal model is required for AD research that reflects the pattern identification. The groups that we have used in this study included Senna folium extracts (SFE), 2,4-dinitrochlorobenzene (DNCB), and normal mice. Therefore, the present study was developed to atopic dermatitis mouse model with spleen deficiency in 2,4-dinitrochlorobenzene (DNCB) and senna leaves extracts induced AD in NC/Nga mice. The results demonstrated that senna leaves extract treatment significantly increased the dermatitis clinical score and epidermal thickness in AD-like skin lesions. We also proved beyond doubt that there was occurrence of erythema and skin moisture indices in the senna leaves extract groups. Further, we also found that the level of serum immunoglobulin E (IgE) in the senna leaves extract-treated group was increased. The amount of IL-4, IL-13, TNF-α and TGF-β mRNA determined by real-time PCR was increased remarkably when senna leaves extract groups were treated on dorsal skin. Senna leaves extract groups significantly promoted the number of CD11B+/Gr-1 cell in skin, as well as the number of CD4+/CD8+ cell in dorsal skin compared with control. The review summarizes recent process in our understanding of the immunopathophysiology of spleen deficiency AD and the implications for spleen deficiency mouse models of AD on drug discovery from medical plants.
Abstract
Atopic dermatitis (AD) is a common skin disease characterized by chronic and relapsing inflammatory dermatitis with immunological disturbances. Spleen deficiency (脾虛) is one of the major causes of AD, so development of animal model is required for AD research that reflects the pattern identification. The groups that we have used in this study included Senna folium extracts (SFE), 2,4-dinitrochlorobenzene (DNCB), and normal mice. Therefore, the present study was developed to atopic dermatitis mouse model with spleen deficiency in 2,4-dinitrochlorobenzene (DNCB) and senna leaves extracts induced AD in NC/Nga mice. The results demonstrated that senna leaves extract treatment significantly increased the dermatitis clinical score and epidermal thickness in AD-like skin lesions. We also proved beyond doubt that there was occurrence of erythema and skin moisture indices in the senna leaves extract groups. Further, we also found that the level of serum immunoglobulin E (IgE) in the senna leaves extract-treated group was increased. The amount of IL-4, IL-13, TNF-α and TGF-β mRNA determined by real-time PCR was increased remarkably when senna leaves extract groups were treated on dorsal skin. Senna leaves extract groups significantly promoted the number of CD11B+/Gr-1 cell in skin, as well as the number of CD4+/CD8+ cell in dorsal skin compared with control. The review summarizes recent process in our understanding of the immunopathophysiology of spleen deficiency AD and the implications for spleen deficiency mouse models of AD on drug discovery from medical plants.
참고문헌 (33)
- Hong SJ., "Report of Korean ISAAC epidemiologic study for asthma and allergic diseases in children", Pediatr Allergy Respir Dis, 17(Suppl 1), pp.S55~S66 (2007)
- "National Health Insurance Corporation" (2014)[URL]
- 오재원, "우리나라 아토피피부염의 치료와 관리의 현실", 천식 및 알레르기, 32(1), pp.14~15 (2012), 대한천식알레르기학회
- 박양, "한국에서 아토피피부염 진단과 치료의 임상적 실태 조사", Allergy Asthma & Respiratory Diseases, 1(3), pp.257~265 (2013), 대한 소아알레르기 호흡기학회
- 한재민, "한의학과 개인맞춤의학에 대한 소고; 변증논치에 근거한 ‘증 기반 개인맞춤의학’", 대한한의학회지, 35(3), pp.40~48 (2014), 대한한의학회
- Traditional Korean Medicine Clinical Practice Guideline-Atopic Dermatitis, "Food and Drug Administration", Food and Drug Administration, 13~17 (2009)
- Korean Institute of Oriental Medicine, "Korean Medicine Clinical Practice Guideline-Atopic Dermatitis", pp.30~37 (2015), Elsevier Korea L.L.C
- 장지혜, "소아 아토피 피부염에 관한 임상적 고찰", 대한한방소아과학회지, 19(2), pp.69~84 (2005), 대한한방소아과학회
- Yun HJ, "Clinical study of atopic dermatitis; classification of oriental medical type and treatment", J Korean Oriental Med, 22(2), pp.10~21 (2001)
- Institute of Oriental Medical Classics, "Lei Bian Huang Di Nei Jing (Class Yellow Emperor’s Inner Canon)", pp.466~471 (2009), Jumin Publishing Company
- Yoon CY, "Study aggregation of "Classic of Difficult Issues(nanjing)"", pp.472~478 (2007), Jumin Publishing Company
- Qu CJ, "Comparative Study on Immunological Changes of Spleen Deficiency Mice in Different Modeling Methods", China Journal of Basic Medicine in Traditional Chinese Medicine, 5(4), pp.46~49 (1999)
- 손병국, "아토피피부염의 변증과 평가방법에 대한 고찰", 한방안이비인후피부과학회지, 21(3), pp.150~165 (2008), 대한한방안이비인후피부과학회
- 정아름누리, "화폐상습진을 동반한 성인형 아토피피부염의 한방 치험 1례", 한방안이비인후피부과학회지, 19(2), pp.296~303 (2006), 대한한방안이비인후피부과학회
- 신상호, "升葛湯을 사용한 아토피 피부염 환자에 대한 임상시험", 한방안이비인후피부과학회지, 20(2), pp.199~212 (2007), 대한한방안이비인후피부과학회
- Chen MJ, "Study on Difference of the Animal's Model about Splenasthenic Syndrome", Master, pp.2005
- Zong SQ, "Experimental Study on Rat Model of Spleen Deficiency Syndrome", Journal of China Medical University, 26(2), pp.206~207 (1997)
- Zhu HW, "Influence of JianPiYangXueQuFengGang on ICAM-1 and VCAM-1 in Mice with Plenoasthenic Eczema", Chin J Derm Venereol, 29(2), pp.193~196 (2015)
- Rokaite R, "Gastrointestinal disorders in children with atopic dermatitis", Medicina(Kaunas), 41(10), pp.837~845 (2005)
- Hsu-Sheng Yu, "Lifetime Increased Risk of Adult Onset Atopic Dermatitis in Adolescent and Adult Patients with Food Allergy", International Journal of Molecular Sciences, 18(12), pp.42~ (2017), MDPI AG[DOI]
- Kim HJ, "Analysis of atopic dermatitis patients according to the Sasang constitution", J Oriental Med Ophthalmol & Otolaryngol & Dermatol, 16(3), pp.200~209 (2003)
- Liu FT, "IgE, mast cells, and eosinophils in atopic dermatitis", Clin Rev Allergy Immunol, 41(3), pp.298~310 (2011)
- Hardy RR, "B cell development pathways", Annu Rev Immunol, 19, pp.595~621 (2001)
- Cooper KD, "Atopic dermatitis : recent trends in pathogenesis and therapy", J Invest Dermatol, 102(1), pp.128~137 (1994)
- Robinson DS, "Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma", N Engl J Med, 326(5), pp.298~304 (1992)
- Hoglund, P, "Induced peripheral regulatory T cells : the family grows larger", Eur J Immunol, 36(2), pp.264~266 (2006)
- Laky K, "TCR and Notch signaling in CD4 and CD8 T-cell development", Immunol Rev, 209(1), pp.274~283 (2006)
- Bromberg JS, "The biology of CD2 : adhesion, transmembrane signal, and regulatory receptor of immunity", J Surg Res, 54(3), pp.258~267 (1993)
- Yamada H, "Overexpression of CD11b on eosinophils in atopic dermatitis: downregulation by cyclosporin A and upregulation by interleukin 5", Int Arch Allergy Immunol, 120(Suppl 1), pp.100~103 (1999)
- Oyoshi MK, "Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation", Immunity, 37(4), pp.747~758 (2012)
- Danso MO, "TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents", J Invest Dermatol, 134(7), pp.1941~1950 (2014)
- de Vries IJ, "Adhesion molecule expression on skin endothelia in atopic dermatitis : effects of TNF-alpha and IL-4", J Allergy Clin Immunol, 102(3), pp.461~468 (1998)
- Lan CC, "Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway : implications on treatment of chronic atopic dermatitis lesions", J Eur Acad Dermatol Venereol, 28(2), pp.204~215 (2014)